Global Bioprocessing Equipment Market Size is valued at USD 64.6 Bn in 2024 and is predicted to reach USD 159.2 Bn by the year 2034 at a 9.7% CAGR during the forecast period for 2025-2034.
The specialized instruments and systems used in the manufacturing of biological products, including vaccines, monoclonal antibodies, enzymes, and biopharmaceuticals, are referred to as bioprocessing equipment. Typically, several intricate procedures are employed to synthesise these compounds from living cells, including bacteria, yeast, or mammalian cells. Widely employed in sectors such as biotechnology, pharmaceuticals, and food and beverage production, bioprocessing equipment is becoming increasingly in demand as biologics and personalized medicine gain more attention worldwide. Rapid developments in synthetic biology, precision medicine, and biopharmaceuticals are driving global demand for bioprocessing equipment.
Additionally, increasing R&D expenditures in biotechnology, the use of disposable and single-use devices, and the integration of AI and machine learning in bioprocessing are significant growth drivers for the bioprocessing equipment market. Furthermore, there is a noticeable trend toward continuous processing techniques, such as perfusion systems. The pharmaceutical, food and beverage, and industrial biotech industries are all seeing new opportunities to increase productivity, quality, and scalability as a result of the integration of Industry 4.0 technology. This will drive the expansion of the bioprocessing equipment market over the forecast period.
However, complex regulatory requirements, quality standards, and the high cost of bioprocessing infrastructure and equipment could hinder market expansion, especially for small and medium-sized biopharmaceutical companies and contract manufacturing organisations (CMOs). Additionally, the market share and pricing dynamics of suppliers and manufacturers of bioprocessing equipment may be impacted by competition from alternative production platforms, outsourcing services, and biosimilar products.
Competitive Landscape
Some Major Key Players In Bioprocessing Equipment Market are:
- Thermo Fisher Scientific Inc.
- Sartorius AG, Merck KGaA
- Eppendorf SE
- Applikon Biotechnology B.V.
- Danaher Corporation, ABEC, Inc
- Pierre Guerin Technologies
- Solaris Biotech Solutions S.r.l.
- Bioengineering AG
- Getinge AB
- Pall Corporation (Cytiva - GE Healthcare)
- Infors HT, CerCell ApS
- Bio-Rad Laboratories, Inc.
The key players in the Bioprocessing Equipment market have shifted their focus toward technological advancement and higher demand for them. They are initiating significant strategies such as mergers and joint ventures of major and domestic players to expand their selection of products and raise their global market footprint. Some of the major key players in the Bioprocessing Equipment market are
Market Segmentation:
The Bioprocessing Equipment market is segmented based on product type, application and end-user. Based on product type, the market is segmented into control and monitoring systems, Bioreactors, Filtration Systems, Fermenters, and Support Equipment. By application, the market is segmented into Food & Beverage, Pharmaceutical & Biopharmaceutical, Environmental, Agricultural, Research & Development, and Industrial Biotechnology. By end-user, the market is segmented into Food & Beverage Manufacturers, Biopharmaceutical and Pharmaceutical Companies, Agricultural Input Companies, Academic & Research Institutions, Contract Development and Manufacturing Organizations (CDMOs/CMOs), Biotechnology and Synthetic Biology Companies, Chemical and Bio-based Product Manufacturers.
Based On The Product Type, The Bioreactors Segment Is Accounted As A Major Contributor To The Bioprocessing Equipment Market
The Bioreactors category is expected to hold a major global market share in 2021 driven by their crucial function in fermentation and cell culture procedures in pharmacological and biotechnological applications. Production optimization and previously unheard-of control over cellular conditions are now possible due to advanced bioreactor technologies, including stirred-tank bioreactors, single-use bioreactors, wave/rocking bioreactors, air-lift bioreactors, and perfusion bioreactors. Additionally, the use of single-use bioreactors is growing at an especially rapid pace as businesses seek to mitigate contamination concerns, eliminate cleaning validation requirements, and enhance manufacturing flexibility.
Biopharmaceutical And Pharmaceutical Companies Segment To Witness Growth At A Rapid Rate
The market for bioprocessing equipment is seeing strong growth in the Biopharmaceutical and Pharmaceutical Companies category due to rising demand for tailored medications, biosimilars, and biologics. To improve productivity, scalability, and regulatory compliance in the manufacturing of vaccines, monoclonal antibodies, and cell and gene treatments, these businesses are making significant investments in cutting-edge bioprocessing technology. The trend toward automation, continuous bioprocessing, and single-use systems has further stimulated new installations and equipment modifications.
In The Region, The North American Bioprocessing Equipment Market Holds A Significant Revenue Share
The North American Bioprocessing Equipment market is expected to register the highest market share in revenue in the near future driven by a sophisticated biotechnology infrastructure, a well-established pharmaceutical industry presence, a strong emphasis on biopharmaceutical development, and a regulatory climate that is conducive to the development and production of biologics.
Additionally, established venture capital markets, extensive intellectual property protection frameworks, and research and development expenditures exceeding USD 200 billion annually provide the best environment for biotechnology innovation and the adoption of bioprocessing equipment in the pharmaceutical, biotechnology, and academic research sectors in this region. In addition, the Asia Pacific is projected to grow rapidly in the global Bioprocessing Equipment market, driven by increased healthcare costs, biotechnology investments, pharmaceutical manufacturing expansion, and demand for biologics. Additionally, the bioprocessing equipment market is expanding more quickly due to the rise in biotechnology incubators and increased awareness of tailored medications.
Bioprocessing Equipment Market Report Scope :
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 64.6 Bn |
|
Revenue Forecast In 2034 |
USD 159.2 Bn |
|
Growth Rate CAGR |
CAGR of 9.7% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Application and End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Eppendorf SE, Applikon Biotechnology B.V., Danaher Corporation, ABEC, Inc., Pierre Guerin Technologies, Solaris Biotech Solutions S.r.l., Bioengineering AG, Getinge AB, Pall Corporation (Cytiva - GE Healthcare), Infors HT, CerCell ApS, and Bio-Rad Laboratories, Inc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
